Bebetter Med secures financing of hundreds of millions of yuan

Bebetter Medhas recently raised hundreds of millions of yuan in latest financing. This round of financing was jointly led by Lucky Source Funds and Yuexiu Industrial Fund, with participation from investment institutions such as Sanmei Investment Management.

Bebetter Medhas recently raised hundreds of millions of yuan in latest financing. This round of financing was jointly led by Lucky Source Funds and Yuexiu Industrial Fund, with participation from investment institutions such as Sanmei Investment Management.

The funding raised in this round will focus on supporting the clinical research and commercialization of its new drug product pipeline.

Bebetter Med was co-founded by Dr. Qian Changgeng and his team in March 2012. It is a completely innovative first-class new drug research and development enterprise, with the goal of developing advanced medicines to treat cancer and other serious diseases.

Through several years of unremitting efforts, the company has established an extensive product pipeline. The indications include lymphoma, breast cancer, lung cancer, ovarian cancer and other blood tumors and solid tumors, as well as non-alcoholic steatohepatitis (NASH), psoriasis, and other major disease areas.

Dr. Qian Changgeng, Chairman and General Manager of Bebetter Med, said: “We are very honored to be recognized and supported by well-known Chinese investment institutions including Lucky Source Funds, Yuexiu Industrial Fund and Sanmei Investment.

After completing this round, we will accelerate the clinical advancement and industrialization of the company ’s product pipeline.

The company will further strengthen its own technology research and development capabilities to bring urgently needed, effective and affordable therapeutic drugs to cancer patients and other patients in major diseases in China as soon as possible.

At the same time, we also hope to use our advantages in small molecule drug design and evaluation, through independent research and development and cooperation with other companies and research institutions at home and abroad, to enhance competitiveness and enrich product pipelines. “

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/05/27/bebetter-med-secures-financing-of-hundreds-of-millions-of-yuan/.

Leave a Reply

Please Login to Comment